Literature DB >> 1396669

Degradation of gangliosides by the lysosomal sialidase requires an activator protein.

R Fingerhut1, G T van der Horst, F W Verheijen, E Conzelmann.   

Abstract

Lysosomal sialidase, which was formerly believed to degrade only water-soluble substrates but not glycolipids, cleaves ganglioside substrates II3NeuNAc-LacCer, IV3NeuNAc, II3NeuNAc-GgOse4Cer, IV3 NeuNAc, II3(NeuNAc)2-GgOse4Cer when these are dispersed either with an appropriate detergent (taurodeoxycholate) or with the sulfatide activator protein, a physiologic lipid solubilizer required for the lysosomal hydrolysis of other glycolipids by water-soluble hydrolases. In the presence of the activator protein, time and protein dependence were linear within wide limits, while the detergent rapidly inactivated the enzyme. The disialo group of the b-series gangliosides was only poorly attacked by the enzyme when the lipids were dispersed with the activator protein, whereas in the presence of the detergent, they were hydrolyzed as fast as terminal sialic acid residues. With the appropriate assay method, significant ganglioside sialidase activity could be demonstrated in the secondary lysosome fraction of normal skin fibroblasts but not of sialidosis fibroblasts. Our results support the notion that there is only one lysosomal sialidase, which degrades both the water-soluble and the membrane-bound sialyl glycoconjugates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396669     DOI: 10.1111/j.1432-1033.1992.tb17227.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Degradation of G(M1) and G(M2) by mammalian sialidases.

Authors:  S C Li; Y T Li; S Moriya; T Miyagi
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

2.  Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides.

Authors:  A Haltia; M L Solin; H Jalanko; C Holmberg; A Miettinen; H Holthöfer
Journal:  Histochem J       Date:  1996-10

Review 3.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

4.  Freeze-stable sialidase activity in human leucocytes: substrate specificity, inhibitor susceptibility, detergent requirements and subcellular localization.

Authors:  P J Waters; A P Corfield; R Eisenthal; C A Pennock
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

Review 5.  Biosynthesis and degradation of mammalian glycosphingolipids.

Authors:  Konrad Sandhoff; Thomas Kolter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

Review 6.  Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.

Authors:  Bernadette Breiden; Konrad Sandhoff
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

7.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.